# Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)

Source: https://welltoldgrants.com/grants/par-21-247-technology-development-for-single-molecule-protein/  
Official notice: https://www.grants.gov/search-results-detail/334700

> National Institutes of Health offered grants to small businesses. Applications closed on June 15, 2023.

| Field | Value |
|---|---|
| Opportunity number | PAR-21-247 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | June 15, 2023 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.172, 93.393, 93.394, 93.395, 93.396, 93.399, 93.855 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

## What the grant funds

This Funding Opportunity Announcement (FOA) solicits grant applications to catalyze major advances in single-molecule protein sequencing through technology development. The goal of this initiative is to achieve technological advances over the next five years that enable generation of protein sequencing data at sufficient scale, speed, cost and accuracy to use routinely in studies of genome biology and function, and in biomedical and clinical research in general.

## Questions people ask

### Is PAR-21-247 still open?

No. It closed on June 15, 2023.

### Who can apply for Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed)?

Closed June 15, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under PAR-21-247?

NIH RePORTER lists 6 projects funded under PAR-21-247 in fiscal 2022 to 2023, at 3 institutions. The most were at Electronic Biosciences, Inc., Glyphic Biotechnologies, Inc., Erisyon Inc.

### Who has won Human Genome Research grants before?

The largest recipients over five fiscal years were The Leland Stanford Junior University, University of Washington, The Broad Institute, Inc. The program made 1,255 awards worth $2.2 billion in that time.